Admission Date:  [**2106-11-12**]              Discharge Date:   [**2106-11-18**]

Date of Birth:  [**2048-10-2**]             Sex:   M

Service: CARDIOTHORACIC

Allergies:
Bacitracin

Attending:[**First Name3 (LF) 4679**]
Chief Complaint:
Gastroesophageal reflux disease.
Gastroparesis.
Tracheobronchomalacia.


Major Surgical or Invasive Procedure:
[**2106-11-12**]: Laparoscopic Nissen fundoplication. Laparoscopic
pyloroplasty, Upper endoscopy.


History of Present Illness:
The patient is a 58-year-old gentleman with a complex past
medical history, including long- standing type 1 diabetes with
resultant gastroparesis as
well as a tracheobronchomalacia and documented gastroesophageal
reflux disease.  He was brought to the operating room today for
a Nissen fundoplication and pyloroplasty.


Past Medical History:
1. IDDM - complicated by gastroparesis and peripheral
neuropathy. On insulin pump.
2. Hypothyroidism
3. Hyperlipidemia
4. CAD - s/p LAD stent in [**2097**]
5. Bipolar disorder
6. ADD
7. OSA - on BIPAP at home but has not been using it.
8. Tracheobronchomalacia s/p tracheal bronchoplasty [**2104-6-5**]
9. Right pleural effusion s/p pleurodesis(FEVI 1.95, FVC
2.13)[**2104-7-4**]
10. Osteoarthritis
11. GERD
12. Lactose intolerance
13. Constipation
14. H/O fundic gland polyp with focal low grade dysplasia [**11-4**]


Social History:
Married with 4 children (2 daughters and 2 adopted sons). [**Name2 (NI) 1403**]
as a teacher for 6th-8th grade special education children.
Denies any tobacco, EtOH, or drug use.


Family History:
Mother with CAD and DM. Father with HTN. Brother healthy. [**Name2 (NI) **]
history of UC/Crohn's.


Physical Exam:
VS:
General: walking in halls in no apparent distress
Card: RRR
Resp: decreased breath sounds otherwise clear
GI: benign
Extr: warm
Incision: abdominal clean, dry intact
Neuro:

Pertinent Results:
[**2106-11-17**] WBC-5.7 RBC-4.13* Hgb-10.2* Hct-32.1* Plt Ct-228
[**2106-11-16**] WBC-9.0 RBC-4.00* Hgb-9.9* Hct-30.9* Plt Ct-232
[**2106-11-12**] WBC-5.8 RBC-3.83* Hgb-9.7* Hct-28.7* Plt Ct-244
[**2106-11-17**] Glucose-225* UreaN-25* Creat-1.2 Na-139 K-4.0 Cl-98
HCO3-27
[**2106-11-16**] Glucose-142* UreaN-28* Creat-1.5* Na-146* K-3.5 Cl-104
HCO3-33*
[**2106-11-12**] Glucose-186* UreaN-56* Creat-2.5* Na-140 K-2.8* Cl-95*
HCO3-35*
[**2106-11-16**] CK(CPK)-996* CK(CPK)-1167* BLOOD CK(CPK)-568*
[**2106-11-17**] Calcium-9.3 Phos-3.3 Mg-2.2

UGI SGL W/O KUB [**2106-11-14**] No evidence for obstruction or leak.

UGI SGL CONTRAST W/ KUB [**2106-11-13**] IMPRESSION: Passage of tiny
amount of contrast through fundoplication site, with holdup of
majority of ingested barium in the distal esophagus. This is
likely related to postoperative edema. Followup radiograph can
be obtained to assess for passage of the residual esophageal
contrast.

Chest CT w/o contrast & Abdomen [**2106-11-14**]: IMPRESSION: No
intra-abdominal or mediastinal collection. Small amount of
debris in the distended gallbladder, possibly sludge or small
calculi without  definite evidence of cholecystitis.

Head CT [**2106-11-14**]  IMPRESSION: No acute abnormality.

Pathology [**2106-11-12**] "Gastroesophageal junction":
1.  Fibroadipose tissue and three hyperplastic lymph nodes.
2.  No tumor.
Clinical:  Gastroesophageal reflux disease.
Gross:

The specimen is received fresh labeled with the patient's name,
"[**Known lastname 10087**], [**Known firstname **]," the medical record number and "GE Junction."
It consists of a fragment of yellow tan adipose tissue measuring
4.1 x 3.1 x 0.5 cm. The specimen is serially sectioned to reveal
unremarkable tan fibrofatty cut surfaces. The specimen is
entirely submitted in A-D.


Brief Hospital Course:
Mr. [**Known lastname 10087**] was admitted on [**2106-11-12**] taken to the operating room
for an uneventful
Laparoscopic Nissen fundoplication. Laparoscopic pyloroplasty.
Upper endoscopy.  He tolerated the procedure well. He was
extubated in the PACU placed on CPAP over night in stable
condition and diuresed with IV lasix prior to transfer to the
floor.  His pain was controlled with a Dilaudid PCA. On POD 1 he
did well. He was restarted on his home medications.  On POD 2 he
had fevers with severe mental status changes requiring transfer
to the SICU.  He was started on Zosyn. He was pancultured with
no growth to date.  Psychiatry was consulted for question of
delirium requiring 4 point restraints and management of his
psychiatric meds.  They recommended not restarting his psych
meds, haldolol prn and allow his mental status to clear. They
continued to follow him and adjust his meds as tolerated. On
[**2106-11-14**]: CT head: normal  CT torso: small amount of debris in
the distended gallbladder UGI SGL: No evidence for obstruction
or leak.  [**Last Name (un) **] was consulted for his Type I diabetes requiring
an insulin drip.  He remained in the SICU until his mental
status improved and his glucose level was stable. On POD 3 he
was started on a clear liquid diet which he tolerated. His home
cardiac medications and neuropathy meds were restarted. On POD 4
he transferred to the floor in stable condition.  His mental
status slowly improved. POD [**4-6**] his lamictal and abilify were
slowly titrated per psychriatry recommendation. His diet was
advanced to soft. Physical therapy saw him and cleared him for
home. He was seen by occupational therapy who made
recommendations for his cognitive dysfunction.  On POD7 he
continued to do well and was discharged to home with VNA to
assist with his medications.  He will follow-up with psychriatry
and outpatient MRI for his history of hullcinations and
cognitive decline.

Medications on Admission:
 Albuterol 90 mcg, Adderall 20 mg, Abilify 30 mg,
Atorvastatin 80 mg, Tessalon 200 mg, Codeine-Guiafenisin,
Flexeril 5 mg, Doxazosin 8 mg, Finasteride 5 mg, Lasix 160 mg
[**Hospital1 **], Neurontin 800 mg, Hydrocodone-Acetominophen, Lamotrigine
200
mcg, Levothyroxine 200 mcg, Levoxyl 25 mcg, Amitiza 24 mcg,
Metoclopramide 10 mg [**Hospital1 **], Metolazone 2.5 mg every other day,
Metoprolol 25 mg daily, Modafinil 200 mg [**Hospital1 **], Nabumetone 750 mg,
Nortriptyline 25 mg tid, Oxycodone, Protonix 40 mg [**Hospital1 **], Spiriva
18 mcg, Trazodone 50 mg, Aspirin 81 mg


Discharge Medications:
1. Tiotropium Bromide 18 mcg Capsule, w/Inhalation Device [**Hospital1 **]:
One (1) Cap Inhalation DAILY (Daily).
2. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device [**Hospital1 **]:
One (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).
3. Aspirin 81 mg Tablet, Chewable [**Hospital1 **]: One (1) Tablet, Chewable
PO DAILY (Daily).
4. Metolazone 2.5 mg Tablet [**Hospital1 **]: One (1) Tablet PO once a day:
Daily as needed for weight gain.
5. Lubiprostone 24 mcg Capsule [**Hospital1 **]: One (1) Capsule PO BID (2
times a day).
6. Doxazosin 8 mg Tablet [**Hospital1 **]: One (1) Tablet PO at bedtime.
7. Lipitor 80 mg Tablet [**Hospital1 **]: One (1) Tablet PO once a day.
8. Albuterol 90 mcg/Actuation Aerosol [**Hospital1 **]: Two (2) puffs
Inhalation every six (6) hours as needed for shortness of breath
or wheezing.
9. Metoclopramide 10 mg Tablet [**Hospital1 **]: Two (2) Tablet PO four times
a day: AC & HS.
10. Benzonatate 100 mg Capsule [**Hospital1 **]: Two (2) Capsule PO DAILY
(Daily).
11. Levothyroxine 25 mcg Tablet [**Hospital1 **]: One (1) Tablet PO DAILY
(Daily).
12. Levothyroxine 100 mcg Tablet [**Hospital1 **]: Two (2) Tablet PO DAILY
(Daily).
13. Metoprolol Tartrate 25 mg Tablet [**Hospital1 **]: One (1) Tablet PO BID
(2 times a day).
14. Furosemide 80 mg Tablet [**Hospital1 **]: One (1) Tablet PO BID (2 times
a day).
15. Finasteride 5 mg Tablet [**Hospital1 **]: One (1) Tablet PO once a day.
16. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) [**Hospital1 **]: One
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).
17. Lactaid Ultra 9,000 unit Tablet [**Hospital1 **]: One (1) Tablet PO once
a day as needed.
18. Vitamins & Minerals     Tablet [**Hospital1 **]: One (1) Tablet PO once a
day.
19. Abilify 10 mg Tablet [**Hospital1 **]: Two (2) Tablet PO at bedtime: then
30 mg hs.
Disp:*60 Tablet(s)* Refills:*2*
20. Lamictal 25 mg Tablet [**Hospital1 **]: T